Furiex Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
06 May 2014	Form 3: Forest Laboratories Inc, 10% owner Holds 0 shares of Common Stock
19 Nov 2013	Form 3: Patel Sailash, Chief Financial Officer Holds 14,948 shares of Common Stock
29 May 2013	Form 3: Davis Stephen, Director No securities owned
19 Feb 2013	Form 3: Invus Public Equities, L.p., 10% owner and 7 others Holds 1,003,400 shares of Common Stock
10 Dec 2010	Form 3: Kaldor Stephen W, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Pharmaceutical Product Development Inc, 10% owner Holds 9,881,340 shares of Common Stock
27 May 2010	Form 3: Covington Paul S, Senior VP-Clinical Operations Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Bondurant Stuart, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Dixon Wendy L, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: McIntyre Gail Frances, Senior Vice President-Research Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Woodworth Marshall H, Vice President??Finance Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Eshelman Fredric N, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Corr Peter B, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Ruscher Robert L, Director Holds 0 shares of No securities beneficially owned
27 May 2010	Form 3: Almenoff June Sherie, President Holds 0 shares of No securities beneficially owned

Comments